Ali Khademhosseini named as 2023 National Academy of Inventors Fellow
Published 2023-12-19 · Original archive entry · Explore research explainers
(LOS ANGELES) – December 18, 2023 - The National Academy of Inventors (NAI) has named Ali Khademhosseini, Ph.D., Director and CEO of the Terasaki Institute for Biomedical Innovation (TIBI), as a 2023 National Academy of Inventors Fellow. This distinctive honor is the highest professional award that is exclusively bestowed upon inventors. The Academy has chosen to honor him for his achievements and contributions to the innovation ecosystem, which vastly influences science, society, and the global economy. Dr. Khademhosseini will be formally recognized at the NAI thirteenth annual meeting on June 18, 2024, where he will be presented with a medal by a senior official from the United States Patent and Trademark Office.
The National Academy of Inventors is a non-profit organization whose aim is to recognize and encourage the work of inventors who hold U.S. patents, to mentor and educate innovative students and to translate its members’ inventions to benefit society. The NAI Fellows program includes extraordinary scientists and innovators who have worked in multi-disciplinary fields to translate their research into impactful commercial technologies.
Dr. Khademhosseini has extensive research and leadership experience in the field of biomedical technology. He has formerly held professorships at UCLA and at Harvard Medical School/MIT. He is recognized as a world-renowned leader in combining micro- and nano-engineering approaches with advanced biomaterials for regenerative medicine applications.
“It is exciting that Dr. Khademhosseini will be recognized with such a highly-acclaimed award,” said Stewart Han, President of the Terasaki Institute for Biomedical Innovation. “We are proud to have such a distinguished and innovative scientist as the Director and CEO of our institute.”
END
The National Academy of Inventors is a non-profit organization whose aim is to recognize and encourage the work of inventors who hold U.S. patents, to mentor and educate innovative students and to translate its members’ inventions to benefit society. The NAI Fellows program includes extraordinary scientists and innovators who have worked in multi-disciplinary fields to translate their research into impactful commercial technologies.
Dr. Khademhosseini has extensive research and leadership experience in the field of biomedical technology. He has formerly held professorships at UCLA and at Harvard Medical School/MIT. He is recognized as a world-renowned leader in combining micro- and nano-engineering approaches with advanced biomaterials for regenerative medicine applications.
“It is exciting that Dr. Khademhosseini will be recognized with such a highly-acclaimed award,” said Stewart Han, President of the Terasaki Institute for Biomedical Innovation. “We are proud to have such a distinguished and innovative scientist as the Director and CEO of our institute.”
END